Evidence map›Paper›PMID 24123684›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Cutting edge: identification of the thymic stromal lymphopoietin-responsive dendritic cell subset critical for initiation of type 2 contact hypersensitivity.

Masayuki Kitajima, Steven F Ziegler

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. TSLP: contrasting roles in cancer.Frontiers in immunology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Review
  15. Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Review
  16. Review
  17. Regulation of the Migration of Distinct Dendritic Cell Subsets.Frontiers in cell and developmental biology · 2021
    Review
  18. TSLP drives acute TThe Journal of allergy and clinical immunology · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Masayuki KitajimaImmunology Program, Benaroya Research Institute, Seattle, WA 98101.
Steven F Ziegler
Center for Infectious Disease Research · USUniversity of Washington · US

Funding

Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and ImmP01HL098067 · NHLBI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2010 to 2014
$13.5M
TSLP Signaling in Dendritic Cells - Aim 3U19AI071130 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DONG, CHEN · 2006 to 2010
$6.1M
TSLP and the Pathophysiology of AsthmaR01AI068731 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2006 to 2016
$4.5M
Regulation of TSLP-Mediated Skin InflammationR01AR055695 · NIAMS · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J, HAMERMAN, JESSICA A · 2009 to 2013
$2.0M
TSLP and Contact HypersensitivityR01AR056113 · NIAMS · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2008 to 2012
$2.0M
NHLBI NIH HHS P01 HL098067NIAID NIH HHS R01 AI068731NIAID NIH HHS U19 AI071130NIAMS NIH HHS R01 AR055695NIAMS NIH HHS R01 AR056113
6 · The paper itself

Abstract

The cytokine thymic stromal lymphopoietin (TSLP) has been implicated in the initiation and progression of allergic inflammation through its ability to activate dendritic cells (DCs). However, the identity of the DC subset that responds to TSLP is not known. In this study we use a CCL17 reporter strain to identify the TSLP-responsive DC subset. In vitro, TSLP induced CD11b(high) DCs to express CCL17, to increase CCR7-mediated migration activity, and to drive Th2 differentiation of naive CD4 T cells. In vivo, following skin sensitization, we found that a subset of Ag-bearing CCL17(+)CD11b(high) migratory DCs, but not Ag-bearing CCL17(-) migratory DCs, in skin lymph nodes were capable of driving Th2 differentiation and were dramatically reduced in TSLPR-deficient mice. Taken together, these results demonstrate that TSLP activated a subset of CD11b(+) DCs in the skin to produce CCL17, upregulate CCR7, and migrate to the draining lymph node to initiate Th2 differentiation.

Indexed as

AnimalsCD11b AntigenCell DifferentiationCell MovementCell ProliferationCells, CulturedChemokine CCL17CytokinesDendritic CellsDermatitis, ContactFemaleLymph NodesMiceMice, Inbred BALB CMice, TransgenicReceptors, CCR7Ccl17 protein, mouseCcr7 protein, mouseCD11b AntigenChemokine CCL17CytokinesReceptors, CCR7Thymic Stromal LymphopoietinTSLP protein, mouse

Identifiers

PMID24123684
PMCPMC3826955
OpenAlexW2096435806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.